Medical Strategy

Considering evidence alongside medical questions and communication needs.

Medical strategy is the work of establishing where scientific knowledge in a therapeutic area is sufficient and where it is not, and planning how that gap might be closed. Its starting point is a question rather than a message.

Defining the evidence gap

When a literature search in a therapeutic area is complete, the picture that emerges is rarely without holes:

• Population gaps — the patient groups studies exclude: older people, renal impairment, pregnancy, multimorbidity.
• Comparison gaps — the absence of any study comparing two options directly.
• Outcome gaps — only surrogate endpoints having been measured.
• Duration gaps — no long-term efficacy or safety data.

Where these gaps go unnamed, it becomes easy to build a narrative that says more than the data supports.

The direction of insight

Medical insight arises from observing the distance between clinical practice and published evidence. What matters is the direction of travel: a process moving from practice towards evidence generates questions; a process seeking support for a conclusion fixed in advance generates selectivity.

Setting priorities

Not every evidence gap carries the same weight. Criteria include the number of patients affected, how far a clinical decision depends on that information, the potential for harm created by present uncertainty, and whether the question is answerable.

Keeping a plan within the evidence

A benefit not yet demonstrated belongs in a plan as an assumption to be tested, not as an expected outcome. That distinction is the line separating a scientific plan from a promotional one. A plan has to be reviewed as new data is published; one that stays fixed while the evidence moves has stopped being evidence-based.